Literature DB >> 29443244

Evaluation and management of a patient with possible cerebral venous thrombosis.

Fernando Barinagarrementeria1, Antonio Arauz1.   

Abstract

Cerebral venous thrombosis (CVT) is a relatively rare form of stroke usually affecting young individuals. CVT is characterized by the diversity of its neurologic manifestations, which require a high level of clinical suspicion for diagnosis and prompt, appropriate treatment. Multiple circumstances have been associated with CVT, such as prior medical conditions, transient situations, certain medications, and some predisposing conditions. Headache, focal neurologic deficit, and seizures are the most frequent clinical manifestations at onset. MRI in combination with venography has become the imaging modality of choice, as this technique has a high sensitivity and specificity for establishing a diagnosis. CT venography is an alternative to MRI because this technique produces similar diagnostic results. Pharmacologic treatment of CVT with anticoagulants is widely accepted. Per 100 cases, the recurrence of CVT is 2.8% and the mortality of CVT is 10%.

Entities:  

Year:  2014        PMID: 29443244      PMCID: PMC5765685          DOI: 10.1212/CPJ.0000000000000079

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  19 in total

Review 1.  Neuroimaging of cerebral venous thrombosis.

Authors:  Mohammad Wasay; Muhammad Azeemuddin
Journal:  J Neuroimaging       Date:  2005-04       Impact factor: 2.486

2.  Stroke and pregnancy.

Authors:  C Jaigobin; F L Silver
Journal:  Stroke       Date:  2000-12       Impact factor: 7.914

Review 3.  Current endovascular treatment options of dural venous sinus thrombosis: a review of the literature.

Authors:  Nihar B Gala; Nitin Agarwal; James Barrese; Chirag D Gandhi; Charles Joseph Prestigiacomo
Journal:  J Neurointerv Surg       Date:  2011-11-23       Impact factor: 5.836

4.  Cerebral venous thrombosis in a Mexican multicenter registry of acute cerebrovascular disease: the RENAMEVASC study.

Authors:  José L Ruiz-Sandoval; Erwin Chiquete; L Jacqueline Bañuelos-Becerra; Carolina Torres-Anguiano; Christian González-Padilla; Antonio Arauz; Carolina León-Jiménez; Luis M Murillo-Bonilla; Jorge Villarreal-Careaga; Fernando Barinagarrementería; Carlos Cantú-Brito
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-03-02       Impact factor: 2.136

5.  Cerebral venous sinus thrombosis: Incidence of venous thrombosis recurrence and survival.

Authors:  I Gosk-Bierska; W Wysokinski; R D Brown; K Karnicki; D Grill; H Wiste; E Wysokinska; R D McBane
Journal:  Neurology       Date:  2006-09-12       Impact factor: 9.910

6.  Cerebrovascular complications during pregnancy and postpartum: clinical and prognosis observations in 240 Hispanic women.

Authors:  C Cantu-Brito; A Arauz; Y Aburto; F Barinagarrementeria; J L Ruiz-Sandoval; J F Baizabal-Carvallo
Journal:  Eur J Neurol       Date:  2010-12-08       Impact factor: 6.089

7.  EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients.

Authors:  K Einhäupl; J Stam; M-G Bousser; S F T M De Bruijn; J M Ferro; I Martinelli; F Masuhr
Journal:  Eur J Neurol       Date:  2010-10       Impact factor: 6.089

Review 8.  Cerebrovascular complications in patients with cancer.

Authors:  Lisa R Rogers
Journal:  Semin Neurol       Date:  2004-12       Impact factor: 3.420

9.  Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).

Authors:  José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2004-02-19       Impact factor: 7.914

Review 10.  Anticoagulation for cerebral sinus thrombosis.

Authors:  J Stam; S F De Bruijn; G DeVeber
Journal:  Cochrane Database Syst Rev       Date:  2002
View more
  1 in total

1.  Clinical stroke challenges: A practical approach.

Authors:  José G Merino
Journal:  Neurol Clin Pract       Date:  2014-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.